Managing chronic coronary syndrome: how do we achieve optimal patient outcomes?

Antonis A Manolis1, Theodora A Manolis2, Antonis S Manolis3

  • 1Department of Medicine, Elpis General Hospital, Athens, Greece.

Insights

Chronic coronary syndrome (CCS) is a major cause of death. This review covers CCS phenotypes, diagnostic methods like CCTA and CAC scoring, and multidisciplinary management including new therapies and cardiac rehabilitation.

Area of Science:

  • Cardiology
  • Cardiovascular Medicine

Background:

  • Chronic coronary syndrome (CCS) is a leading global cause of mortality and high hospitalization rates.
  • Understanding CCS phenotypes is crucial for effective patient management.

Purpose of the Study:

  • To review current diagnostic modalities for CCS, including noninvasive and invasive testing.
  • To discuss multidisciplinary management strategies and emerging therapeutic options for CCS.
  • To highlight the role of cardiac rehabilitation and advanced treatments for refractory symptoms.

Main Methods:

  • Literature search of medical databases for CCS and its management.
  • Review of diagnostic techniques: stress-echocardiography, coronary computed-tomography angiography (CCTA), coronary artery calcium (CAC) scoring, echocardiography, and biomarkers.
  • Analysis of multidisciplinary management approaches, including risk factor modification, pharmacotherapies, and revascularization.
  • Evaluation of newer treatments (colchicine, ivabradine, ranolazine, melatonin), cardiac rehabilitation, implantable defibrillators (ICD), and extracorporeal shockwave-revascularization.

Main Results:

  • Stress-echocardiography defines CCS phenotypes.
  • CAC scoring and CCTA are key for assessing atherosclerosis burden and functional significance.
  • Multidisciplinary CCS management involves risk factor control, anti-inflammatory/anti-ischemic/antithrombotic therapies, and revascularization.
  • Emerging therapies and cardiac rehabilitation improve outcomes and quality of life.

Conclusions:

  • Effective CCS management requires a multidisciplinary approach integrating advanced diagnostics and tailored therapies.
  • Newer pharmacological agents and lifestyle interventions like cardiac rehabilitation are vital for improving patient prognosis and quality of life.
  • Advanced treatments offer options for refractory CCS symptoms and sudden cardiac death prevention.
Abstract

Related Concept Videos

Chronic Obstructive Pulmonary Disease-V: Management01:29

Chronic Obstructive Pulmonary Disease-V: Management

Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
2.5K
Chronic Obstructive Pulmonary Disease-V: Nursing Management01:30

Chronic Obstructive Pulmonary Disease-V: Nursing Management

Nursing management of Chronic Obstructive Pulmonary Disease (COPD) is crucial for providing thorough care and support to patients. Nurses play an integral role in this process through detailed assessment, careful planning, targeted interventions, and ongoing evaluation. Here's an overview of the critical steps in nursing management for COPD.
Assessment
3.8K
Chronic Pancreatitis II: Collaborative Care01:29

Chronic Pancreatitis II: Collaborative Care

The management of chronic pancreatitis is multifaceted, involving a comprehensive approach that includes thorough assessment, diagnostic testing, and a variety of management strategies.
Assessment:
85
COPD: Management Using Bronchodilators and Corticosteroids01:26

COPD: Management Using Bronchodilators and Corticosteroids

Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
197
Antianginal Drugs: Calcium Channel Blockers and Ranolazine01:25

Antianginal Drugs: Calcium Channel Blockers and Ranolazine

Angina pectoris, a primary symptom of ischemic heart disease, requires careful pharmacological interventions. In this context, calcium channel blockers (CCBs) and ranolazine have emerged as crucial pharmacotherapeutic agents, providing deep insights into the complexities of angina management.
CCBs, a diverse class that includes dihydropyridines (nifedipine) and diphenylalkylamines (verapamil and diltiazem), exert their effect by blocking calcium channels in cardiac and smooth muscle cells. This...
493